If you read the article, the &quot;complexity&quot; refers to the lack of translation from bench to clinic. IP is the fundamental currency to attract investment to get scientific discoveries through the regulatory process. You can still have &quot;open science&quot; in the sense you are using this term and have patents; see CRISPR&#x2F;Cas9 as a prime example.